Recent Increase In Multiple Myeloma Survival Attributed To Novel Therapies

Multiple myeloma is one of the most common and devastating bone marrow cancers in the U.S., but survival rates have risen dramatically over the past decade. Recent analyses suggest that this trend may be attributed to new types of drugs and aggressive therapeutic interventions such as stem cell transplantation, according to the results of two studies prepublished online in Blood, the official journal of the American Society of Hematology. [click link for full article]

More: continued here

Filed under: Bones on November 3rd, 2007